Dasiglucagon: payments to doctors
Payments that named Dasiglucagon as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $60K
- Providers
- 12
- Transactions
- 17
- Average per transaction
- $3,515
The per-transaction average — $3,515 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12 providers the average total is $4,980, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Zealand Pharma A/s | $59,762 | 100.0% |